In vitro metabolic fate of a novel structural class: Evidence for the formation of a reactive intermediate on a benzothiophene moiety
- 28 February 2005
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 152 (1) , 25-36
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The Use of Radiolabeled Compounds for ADME Studies in Discovery and Exploratory DevelopmentCurrent Pharmaceutical Design, 2004
- Drug−Protein Adducts: An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and DevelopmentChemical Research in Toxicology, 2003
- Screening for the potential of a drug candidate to cause idiosyncratic drug reactionsDrug Discovery Today, 2003
- In Vitro Metabolism of R(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a Cannabinoid Receptor AgonistDrug Metabolism and Disposition, 2002
- Peer Reviewed: Systematic LC/MS Metabolite Identification in Drug DiscoveryAnalytical Chemistry, 2001
- Idiosyncratic drug reactions: the reactive metabolite syndromesThe Lancet, 2000
- Metabolic Activation of Diclofenac by Human Cytochrome P450 3A4: Role of 5-HydroxydiclofenacChemical Research in Toxicology, 1999
- Covalent Binding of a Reactive Metabolite Derived from Propranolol and Its Active Metabolite 4-Hydroxypropranolol to Hepatic Microsomal Proteins of the RatChemical Research in Toxicology, 1997
- Diclofenac Covalent Protein Binding Is Dependent on Acyl Glucuronide Formation and Is Inversely Related to P450-Mediated Acute Cell Injury in Cultured Rat HepatocytesToxicology and Applied Pharmacology, 1993
- An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitroBiochemical Pharmacology, 1992